Omega fourth quarter net income decreases to $5.0 million

Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") today announced its results of operations for the quarter and fiscal year ended December 31, 2010. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three months ended December 31, 2010 of $28.4 million or $0.29 per common share. The $28.4 million of FFO available to common stockholders for the fourth quarter of 2010 includes interest refinancing costs of approximately $16.0 million, $0.5 million of non-cash restricted stock expense, a $149 thousand net loss associated with owned and operated assets and $64 thousand of costs associated with 2010 acquisitions. The $16.0 million of interest refinancing costs related to the write-off of deferred financing costs and prepayment costs associated with (i) the repayment of a $100 million term loan and the (ii) tender and redemption of all of the Company's outstanding $310 million, 7% Senior Notes due 2014. FFO is presented in accordance with the guidelines for the calculation and reporting of FFO issued by the National Association of Real Estate Investment Trusts ("NAREIT"). Adjusted FFO was $0.46 per common share for the three months ended December 31, 2010. FFO and Adjusted FFO are non-GAAP financial measures. Adjusted FFO is calculated as FFO available to common stockholders less certain non-cash items and certain items of revenue or expense, including, but not limited to: results of operations of owned and operated facilities during the period, expenses associated with acquisitions and restricted stock expense. For more information regarding FFO and Adjusted FFO, see the "Funds From Operations" section below.

GAAP NET INCOME

For the three-month period ended December 31, 2010, the Company reported net income of $5.0 million and net income available to common stockholders of $2.7 million, or $0.03 per diluted common share on operating revenues of $71.1 million. This compares to net income of $16.2 million and net income available to common stockholders of $14.0 million, or $0.16 per diluted common share on operating revenues of $49.4 million, for the same period in 2009.

For the twelve-month period ended December 31, 2010, the Company reported net income of $58.4 million, net income available to common stockholders of $49.4 million, or $0.52 per diluted common share on operating revenues of $258.3 million. This compares to net income of $82.1 million, net income available to common stockholders of $73.0 million, or $0.87 per diluted common share on operating revenues of $197.4 million, for the same period in 2009.

The year-to-date decreases in both net income and net income available to common stockholders were primarily due to: (i) costs related to the early retirement of debt obligations in 2010; (ii) increased depreciation expense associated with approximately $900 million of new investments (including capital improvements) made throughout 2009 and 2010; (iii) increased interest expense associated with debt instruments issued in 2010; (iv) increased interest expense associated with debt assumed in connection with the CapitalSource Inc. ("CapitalSource") asset acquisitions; (v) the incremental impact of proceeds received from a 2009 legal settlement versus a 2010 legal settlement; and (vi) increased general and administrative expenses resulting from the new investments. This impact was partially offset by: (a) revenue associated with the new investments completed in 2010; (b) a $1.5 million reduction in the net loss associated with owned and operated assets; and (c) $0.8 million gain from two mortgage backed securities that were sold in the second quarter of 2010.

2010 SIGNIFICANT HIGHLIGHTS AND OTHER RECENT DEVELOPMENTS

• In January 2010, the Company increased its quarterly common dividend per share from $0.30 to $0.32.
• In February 2010, the Company issued $200 million aggregate principal amount of its 7 ½% senior unsecured notes due 2020.
• In February 2010, the Company repaid $59 million of mortgage debt it assumed as part of the December 2009 CapitalSource asset acquisition.
• In April 2010, the Company entered into a new $320 million revolving senior secured credit facility.
• In June 2010, the Company closed on the purchase of the remaining 103 long-term care facilities from CapitalSource for $589 million.
• In June 2010, the Company established a $140 million 2010 Equity Shelf Program for a continuous at-the-market offering of common stock.
• In July 2010, the Company increased its quarterly common dividend per share from $0.32 to $0.36.
• In October 2010, the Company issued $225 million aggregate principal amount of its 6¾% senior unsecured notes due 2022.
• In October 2010, the Company terminated and repaid its $100 million Credit Agreement with General Electric Capital Corporation.
• In October 2010, the Company increased its quarterly common dividend per share from $0.36 to $0.37.
• In October 2010, the Company announced an exchange offer for its outstanding $200 million 7½% Senior Notes due 2020 issued in February 2010.
• In November 2010, the Company issued $350 million aggregate principal amount of its 6¾% senior unsecured notes due 2022.
• During the fourth quarter of 2010, the Company tendered and/or redeemed all of its outstanding $310 million 7% Senior Notes due 2014.
• During the twelve-months ended December 31, 2010, the Company sold 6.7 million shares of its common stock under its Equity Shelf Program generating net proceeds of $139 million.
• During the twelve-months ended December 31, 2010, the Company sold 3.0 million shares of its common stock under its Dividend Reinvestment and Direct Stock Purchase Program generating net proceeds of $61 million.
• In February 2011, the Company called all of its outstanding shares of 8.375% Series D Cumulative Redeemable Preferred Stock, valued at $108.5 million, for redemption on March 7, 2011.

FOURTH QUARTER 2010 RESULTS

Operating Revenues and Expenses - Operating revenues for the three months ended December 31, 2010, excluding nursing home revenues of owned and operated assets and therefore on a non-GAAP basis, were $71.1 million. Operating expenses for the three months ended December 31, 2010, excluding nursing home expenses for owned and operated assets, totaled $29.1 million, and was comprised of $25.7 million of depreciation and amortization expense, $2.8 million of general and administrative expense, $0.5 million of restricted stock expense and $64 thousand of expense associated with the CapitalSource asset acquisitions. A reconciliation of these amounts to revenues and expenses reported in accordance with GAAP is provided at the end of this release.

Other Income and Expense - Other income and expense for the three months ended December 31, 2010 was a net expense of $36.9 million and was primarily comprised of $20.0 million of interest expense, $0.9 million of amortized deferred financing costs and $16.0 million of interest refinancing expense related to the early retirement of debt obligations in 2010.

Funds From Operations - For the three months ended December 31, 2010, reportable FFO available to common stockholders was $28.4 million, or $0.29 per common share on 99 million weighted-average common shares outstanding, compared to $24.9 million, or $0.29 per common share on 86 million weighted-average common shares outstanding, for the same period in 2009.

The $28.4 million of FFO for the three months ended December 31, 2010 includes the impact of approximately $16.0 million in interest refinancing expense, $0.5 million of non-cash restricted stock expense, a $149 thousand net loss associated with owned and operated assets and $64 thousand of costs associated with 2010 acquisitions. The $16.0 million of interest refinancing costs related to the write-off of deferred financing costs and prepayment costs associated with the (i) repayment of a $100 million term loan and (ii) tender and redemption of all of the Company's outstanding $310 million, 7% Senior Notes due 2014.

The $24.9 million of FFO for the three months ended December 31, 2009 includes the impact of $3.9 million in uncollectible accounts receivable and deferred revenue related to one operator, $1.6 million of acquisition deal related expense, $0.5 million of non-cash restricted stock expense, and $3 thousand of net income associated with owned and operated assets.

Adjusted FFO was $45.1 million, or $0.46 per common share, for the three months ended December 31, 2010, compared to $30.8 million, or $0.36 per common share, for the same period in 2009. The Company had 13.3 million additional weighted-average shares for the three months ended December 31, 2010 compared to the same period in 2009. The increase in weighted-average common shares was primarily a result of: (i) approximately 6.9 million common shares issued under the Company's 2009 and 2010 Equity Shelf Programs; (ii) approximately 3.7 million shares of common stock issued to CapitalSource as part of the December 2009 and June 29, 2010 asset acquisitions; and (iii) approximately 3.0 million common shares issued under the Company's Dividend Reinvestment and Common Stock Purchase Plan. For further information see "Funds From Operations" below.

2010 ANNUAL RESULTS

Operating Revenues and Expenses - Operating revenues for the twelve months ended December 31, 2010, when excluding nursing home revenues of owned and operated assets, were $251.0 million. Operating expenses for the twelve months ended December 31, 2010, when excluding nursing home expenses of owned and operated assets, totaled $101.4 million, and was comprised of $84.6 million of depreciation and amortization expense, $12.8 million of general and administrative expense, $2.2 million of restricted stock compensation expense, $1.6 million of acquisition deal related expense, and a non-cash real estate impairment of $0.2 million.

Other Income and Expense - Other income and expense for the twelve months ended December 31, 2010 was a net expense of $90.5 million and was primarily comprised of $67.3 million of interest expense, $3.8 million of deferred financing amortization costs and $19.5 million of interest refinancing expenses.

Funds From Operations - For the twelve months ended December 31, 2010, reportable FFO available to common stockholders was $134.0 million, or $1.42 per common share, compared to $117.0 million, or $1.40 per common share, for the same period in 2009. The $134.0 million of FFO for 2010 includes the impact of: (i) $19.5 million of interest refinancing expense; (ii) $2.2 million of non-cash restricted stock expense; (iii) $1.6 million of acquisition deal related expense; (iv) $1.1 million in proceeds associated with a legal settlement; (v) an $0.8 million gain on the sales of two mortgage backed securities that were bought in the first quarter of 2010 and sold in the second quarter of 2010; (vi) a $0.7 million net loss associated with owned and operated assets; and (vii) a real estate impairment of $0.2 million. The $19.5 million of interest refinancing expense was comprised of: (a) a charge of approximately $3.5 million related to the write-off of deferred financing costs associated with the termination of the Company's 2009 credit facility in the second quarter of 2010; (b) $5.2 million related to the write-off of deferred financing costs and a penalty payment associated with the $100 million GECC term loan paid-off in October 2010; and (c) $10.8 million related to the tender and redemption of all of the Company's outstanding $310 million 7% Senior Notes due 2014.

The $117.0 million of FFO for twelve months ended December 31, 2009 includes: (i) a $4.5 million legal settlement; (ii) $3.9 million in uncollectible accounts receivable and deferred revenue related to one operator; (iii) a $2.2 million net loss associated with owned and operated assets; (iv) $1.9 million of non-cash restricted stock expense; (v) $1.6 million of acquisition deal related expense; (vi) $0.5 million write-off of deferred financing credit facility costs; and (vii) $0.2 million of a real estate impairment.

When excluding the above mentioned non-cash or non-recurring items in 2010 and 2009, adjusted FFO was $156.1 million, or $1.66 per common share for the twelve months ended December 31, 2010, compared to $122.7 million, or $1.47 per common share, for the same period in 2009. For further information see the attached "Funds From Operations" schedule and notes.

2010 FINANCING ACTIVITIES

$350 Million Senior Notes Issuance - On November 23, 2010, the Company sold $350 million aggregate principal amount of its 6¾% Senior Notes due 2022. These notes were sold at an issue price equal to 103% of their face value (equivalent to a 6.26% yield per annum), before the initial purchasers' discount resulting in gross proceeds to the Company of approximately $361 million.

Tender and Redemption of $310 Million 7% Senior Notes due 2014 - On November 8, 2010, the Company commenced a tender offer to purchase for cash any and all of its outstanding $310 million aggregate principal amount of 7% Senior Notes due 2014 (the "2014 Notes"). Omega paid holders of the 2014 Notes consent payments aggregating approximately $7.9 million over the face amount of the 2014 Notes, and wrote-off approximately $3.1 million of deferred financing costs and other related expenses in connection with the repurchase. Pursuant to the terms of the tender offer, which expired on December 8, 2010, Omega purchased $264.7 million aggregate principal amount of the 2014 Notes.

On December 16, 2010, the Company redeemed the remaining $45.3 million aggregate principal amount of the 2014 Notes at a redemption price of 102.333% of the principal amount thereof, plus accrued and unpaid interest on the 2014 Notes up to the redemption date. Upon redemption, the 2014 Notes, the Indenture governing the 2014 Notes and the related guarantees were terminated.

$200 Million Senior Notes Exchange - On October 20, 2010, the Company exchanged $200 million of its 7½% Senior Notes due 2020 (the "2020 Notes") that had been registered under the Securities Act of 1933 for $200 million of its outstanding 7½% Senior Notes due 2020. The 2020 Notes were sold in February 2010 in a private placement at an issue price of 98.278% of the principal amount of the 2020 Notes resulting in gross proceeds to the Company of approximately $197 million.

$100 Million Term Loan Repayment - On October 6, 2010, the Company terminated its Credit Agreement with General Electric Capital Corporation. The Credit Agreement previously provided the Company with a five-year $100 million term loan. In connection with the termination, the Company repaid the outstanding principal amount of the loan plus a prepayment premium of $3 million. As a result, for the three month period ended December 31, 2010, the Company recorded a non-cash charge of approximately $2.2 million relating to the write-off of deferred financing costs associated with the termination of the Credit Agreement.

$225 Million Senior Notes Issuance - On October 4, 2010, the Company sold $225 million aggregate principal amount of its 6¾% Senior Notes due 2022. These notes were sold at an issue price of 98.984% of the principal amount of the notes resulting in gross proceeds to the Company of approximately $223 million.

1.0 Million Share Common Stock Issuance - On June 29, 2010, the Company issued 1.0 million shares of its common stock to CapitalSource as part of the June 29, 2010 CapitalSource asset acquisition. For further information see the "Portfolio Developments" section below.

$140 Million 2010 Equity Shelf Program - On June 25, 2010, the Company entered into separate equity distribution agreements to sell shares of its common stock having an aggregate gross sales price of up to $140,000,000 (the "Agreements") with several financial institutions, each as sales agents and/or principal (collectively, the "Managers"). Under the terms of the Agreements, the Company may from time to time offer and sell shares of its common stock having an aggregate gross sales price of up to $140,000,000 through or to the Managers. Sales of the shares, if any, will be made by means of ordinary brokers' transactions on the New York Stock Exchange at market prices, or as otherwise agreed with the Managers. The Company will pay each Manager, in its capacity as sales agent, a fee equal to 2% of the gross sales price of shares sold through such Manager.

$320 Million Credit Facility - On April 13, 2010, the Company entered into a new $320 million revolving senior secured credit facility (the "2010 Credit Facility"). The 2010 Credit Facility replaced the Company's previous $200 million revolving senior secured credit facility (the "2009 Credit Facility"). The 2010 Credit Facility matures on April 13, 2014. The 2010 Credit Facility includes an "accordion feature" that permits the Company to expand its borrowing capacity to $420 million during its first three years.

The 2010 Credit Facility is priced at LIBOR plus an applicable margin (ranging from 325 basis points to 425 basis points) based on the Company's consolidated leverage and is not subject to a LIBOR floor.

For the three month period ended June 30, 2010, the Company recorded a charge of approximately $3.5 million relating to the write-off of deferred financing costs associated with the termination of the 2009 Credit Facility.

$59 Million Mortgage Debt Repayment - In connection with the December 2009 CapitalSource asset acquisition, the Company assumed $59.4 million of 6.8% mortgage debt maturing on December 31, 2011. Proceeds from the 2020 Notes sold in February 2010 were used to repay the assumed mortgage debt on February 16, 2010.

Equity Shelf Program and the Dividend Reinvestment and Direct Stock Purchase Plan - During the twelve-months ended December 31, 2010, the Company sold the following shares of its common stock:

2010 PORTFOLIO DEVELOPMENTS AND RECENT DEVELOPMENTS

Formation Capital, Connecticut Facilities - In January 2011, upon the Company's request, a complaint was filed by the State of Connecticut, Commissioner of Social Services, the Superior Court, Judicial District of Hartford, Connecticut appointing a receiver to oversee the Company's four Connecticut skilled nursing facilities ("SNFs"). The facilities were leased and operated by affiliates of Formation Capital ("Formation") and were managed by Genesis HealthCare ("Genesis").

The receiver is responsible for operating the facilities and funding all operational expenses incurred after the appointment of the receiver. It is anticipated that the receiver will establish a bidding process and procedure for the leasehold interests that are the subject of the receivership action, and it is anticipated that the receiver will coordinate with the Company in respect of the bidding process and the ultimate transition of the facilities to a new operator via the sale of the leasehold interests. It is, however, possible that the receiver will recommend the closure of one or more of these facilities. At December 31, 2010, the Company had a net investment of approximately $26 million in these four facilities.

The remaining eleven Formation facilities continue to be leased by Formation under the existing Master Lease, and managed by Genesis.

Mortgage Loan - In December 2010, the Company entered into a $15.9 million first mortgage loan with a new operator. The loan encompasses three SNFs, totaling 240 beds, located in Florida. The term of the mortgage is 20 years and bears an initial interest rate of 10%, with annual escalators.

Construction-to-Permanent Mortgage Loans - In August 2010, the Company agreed to extend four construction-to-permanent mortgage loans to affiliates of Ciena Health Care Management Inc. for the purpose of constructing four new SNFs in Michigan. Each of the loans will have a ten year maturity from the completion of construction of the applicable facility and will bear interest at an annual rate of 12.5%. As of December 31, 2010, the Company disbursed approximately $4.2 million for the construction of a 120 bed facility and approximately $0.6 million for the construction of a 113 bed facility both located in Michigan.

CapitalSource Acquisitions - On June 29, 2010, the Company purchased 40 long-term care facilities from affiliates of CapitalSource pursuant to the securities purchase agreement executed and announced in November of 2009, for an aggregate purchase price of approximately $270 million, consisting of the assumption of $182 million of indebtedness guaranteed by the U.S. Department of Housing and Urban Development ("HUD"), $20 million of other indebtedness, $65 million cash and $3 million of Omega common stock. In addition, Omega issued to an affiliate of CapitalSource an additional $15 million of Omega common stock as consideration for certain escrow amounts transferred at closing.

The $182.0 million of assumed HUD debt is comprised of 29 HUD mortgage loans. Eleven of the HUD loans had a face value of $53.2 million with a blended interest rate of 6.61% and maturities between January 2036 and May 2040. The face value of the remaining 18 HUD loans assumed was $128.8 million with an interest rate of 4.85% and maturities between January 2040 and January 2045. The $20 million of other indebtedness was comprised of five separate $4.0 million subordinated 9% notes that mature in December 2021.

On June 9, 2010, the Company purchased 63 long-term care facilities from affiliates of CapitalSource for an aggregate purchase price of approximately $293 million in cash.

The combined 103 facilities acquired from CapitalSource, representing 11,409 available beds located in 20 states, are part of 43 in-place triple net leases among 20 operators.

Owned and Operated Assets - On June 1, 2010, the two Vermont owned and operated facilities had their license transferred to a third party operator, and the facilities are now part of the Formation Capital ("Formation") master lease. In 2008, Genesis Healthcare ("Genesis") entered into a long-term management agreement with Formation to oversee the day-to-day operations of these two facilities. The Company's consolidated financial statements include the financial position and results of operations of the Vermont facilities from July 7, 2008 to May 31, 2010. As a result of the transition to Formation, effective June 1, 2010, and since the Company no longer operates any facilities, the revenues and expenses of these entities are not included in the Company's consolidated statements of income after June 1, 2010.

DIVIDENDS

Common Dividends - On January 14, 2011, the Company's Board of Directors announced a common stock dividend of $0.37 per share. The common dividend was paid February 15, 2011 to common stockholders of record on January 31, 2011.

Series D Preferred Dividends - On January 14, 2011, the Company's Board of Directors also declared its regular quarterly dividend for the 8.375% Series D Cumulative Redeemable Preferred Stock ("Series D Preferred Stock"). The preferred dividend was paid February 15, 2011 to preferred stockholders of record on January 31, 2011. Series D Preferred Stockholders of record were paid dividends in the approximate amount of $0.52344 per preferred share. The liquidation preference for the Company's Series D Preferred Stock is $25.00 per share. Regular quarterly preferred dividends represent dividends for the period November 1, 2010 through January 31, 2011.

Series D Preferred Redemption - On February 3, 2011, the Company announced that it has called for redemption all of the outstanding shares of its 8.375% Series D Cumulative Redeemable Preferred Stock (NYSE:OHIPRD; CUSIP: 681936-40-7).

The redemption date for the Series D Preferred Stock will be March 7, 2011, and the redemption price will be $25.00 per share of Series D Preferred Stock plus accrued and unpaid dividends up to and including the redemption date, for an aggregate redemption price of $25.21519 per share. On and after the redemption date, dividends on the shares of Series D Preferred Stock will cease to accrue, the Series D Preferred Stock will cease to be outstanding, and holders of the Series D Preferred Stock will have only the right to receive the redemption price.

In connection with the redemption of the Series D Preferred Stock, the Company will write-off $3.4 million of preferred stock issuance costs that will reduce first quarter 2011 net income attributable to common stockholders by approximately $0.03 per common share.

2011 ADJUSTED FFO GUIDANCE

The Company currently expects its 2011 Adjusted FFO available to common stockholders to be between $1.80 and $1.86 per diluted share.

The Company's Adjusted FFO guidance for 2011 excludes the impact of gains and losses from the sale of assets, additional divestitures, certain revenue and expense items, capital transactions and restricted stock amortization expense. A reconciliation of the Adjusted FFO guidance to the Company's projected GAAP earnings is provided on a schedule attached to this press release. The Company may, from time to time, update its publicly announced Adjusted FFO guidance, but it is not obligated to do so.

The Company's Adjusted FFO guidance is based on a number of assumptions, which are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company's expectations may change. Without limiting the generality of the foregoing, the completion of acquisitions, divestitures, capital and financing transactions, and variations in restricted stock amortization expense, that may cause actual results to vary materially from our current expectations. There can be no assurance that the Company will achieve its projected results.

TAX TREATMENT FOR 2010 DIVIDENDS

Common Dividends - On February 16, 2010, May 17, 2010, August 16, 2010 and November 15, 2010, the Company paid dividends to its common stockholders in the per share amounts of $0.32, $0.32, $0.36 and $0.37, for stockholders of record on January 29, 2010, April 30, 2010, July 30, 2010 and October 29, 2010, respectively. The Company has determined that 43.26% of the common dividends paid in 2010 should be treated for tax purposes as a return of capital, with the balance of 56.74% treated as an ordinary dividend.

Preferred D Dividends -The Company has determined that 100% of all dividends on Series D Preferred Stock in 2010 should be treated for tax purposes as an ordinary dividend.